Adicet reports positive Phase 1 prula-cel data; 54% DORIS, 50% CRR at 12 months, favorable safety

Adicet reported positive Phase 1 prula-cel data showing 54% DORIS remission and 50% complete renal response at 12 months with a favorable safety profile.Key Highlights:Original SEC Filing: Adicet Bio, Inc. [ ACET ] - 8-K - Sep. 28, 2026This is an AI-powered summary. It may contain inaccuracies. Con…